iSOFT Signs Sixth LORENZO Site in Germany

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that Christophorus-Kliniken will become the sixth early adopter of iSOFT’s LORENZO next-generation solution in Germany as part of an agreement to upgrade hospital information systems (HIS) at its three hospitals in the Coesfeld district of North Rhine-Westphalia.

The five-year deal potentially is worth as much as €1.43 million (A$2.5 million). The initial two phases, which include the first LORENZO components and an upgrade of iSOFT's ClinicCentre HIS solution, are valued at €675,000 (A$1.2 million) in license fees and services plus €257,000 (A$447,000) in support and maintenance services over five years. An optional third phase, which includes additional LORENZO functionality, is worth a potential €500,000 (A$870,000).

"This is further evidence that our new LORENZO technology is gaining traction with our existing client base in Europe," said Gary Cohen, iSOFT's Executive Chairman & CEO. "It's part of our broader strategy for LORENZO outside of the UK's National Programme for Information Technology."

The first LORENZO elements and iSOFT's Collaboration Suite (iCS) will provide a new electronic patient record (EPR) for GP's to access hospital patient records using standard web browsers. iCS allows the secure exchange of patient information between care providers to improve collaboration between teams.

Christophorus-Kliniken follows Klinikum Saarbrücken, which recently became iSOFT's fifth LORENZO early adopter in Germany. The three Christophorus-Kliniken hospitals covered by the new contract are Coesfeld's St Vincenz Hospital, Franz Hospital at Dülmen and St Gerburgis Hospital at Nottuln, which provide a total of 620 beds and employ 1,500 staff.

Christophorus-Kliniken is an existing client for iSOFT's ClinicCentre and its LabCentre laboratory information system and BusinessCentre finance, administration and management solution.

Other LORENZO early adopters in Germany are Aachen, Leipzig, Krankenhaus Buchholz and Winsen, and Klinikum Saarbrücken.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 16 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

Do Fitness Apps do More Harm than Good?

A study published in the British Journal of Health Psychology reveals the negative behavioral and psychological consequences of commercial fitness apps reported by users on social media. These impacts may...

AI Tool Beats Humans at Detecting Parasi…

Scientists at ARUP Laboratories have developed an artificial intelligence (AI) tool that detects intestinal parasites in stool samples more quickly and accurately than traditional methods, potentially transforming how labs diagnose...

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...

AI can Better Predict Future Risk for He…

A landmark study led by University' experts has shown that artificial intelligence can better predict how doctors should treat patients following a heart attack. The study, conducted by an international...

A New AI Model Improves the Prediction o…

Breast cancer is the most commonly diagnosed form of cancer in the world among women, with more than 2.3 million cases a year, and continues to be one of the...

AI System Finds Crucial Clues for Diagno…

Doctors often must make critical decisions in minutes, relying on incomplete information. While electronic health records contain vast amounts of patient data, much of it remains difficult to interpret quickly...